ROQUEFORT THERAPEUTICS PLC Logo

ROQUEFORT THERAPEUTICS PLC

ROQ | IL

Overview

Corporate Details

ISIN(s):
GB00BMDQ2T15
LEI:
254900P4SISIWOR9RH34
Country:
United Kingdom
Address:
85 Great Portland Street, W1W 7LT London
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Roquefort Therapeutics is a biotechnology company focused on developing first-in-class, next-generation medicines for hard-to-treat cancers. The company's portfolio consists of five novel, patent-protected, pre-clinical programs targeting the high-growth immuno-oncology market, with a specific focus on cancers resistant to existing therapies. Operating a scalable and cost-effective distributed R&D model, Roquefort Therapeutics leverages its in-house expertise, access to state-of-the-art laboratory facilities, and a network of partnerships with leading academic cancer research centers. Founded in 2020, the company aims to advance its complementary portfolio of anti-cancer medicines through pre-clinical development.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for ROQUEFORT THERAPEUTICS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-07 08:00
Director's Dealing
Director/PDMR Shareholding
English 24.3 KB
2025-06-30 08:00
Director's Dealing
Director/PDMR Shareholding
English 24.4 KB
2025-06-27 08:00
M&A Activity
Lyramid SPA Extension
English 14.1 KB
2025-06-26 14:00
Declaration of Voting Results & Voting Rights Announcements
Results of AGM
English 25.0 KB
2025-06-02 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting
English 10.3 KB
2025-05-23 08:00
Capital/Financing Update
Extension of Convertible Loan Notes
English 11.9 KB
2025-05-20 08:50
Annual Report (ESEF)
2024 Annual Report
English 1.8 MB
2025-05-20 08:50
Annual Report
2024 Annual Report
English 3.9 MB
2025-03-14 08:00
Capital/Financing Update
Private Placing and Conversion of CLNs
English 14.5 KB
2025-03-10 08:30
Board/Management Information
Board Changes
English 14.4 KB
2025-03-10 08:00
M&A Activity
Proposed Sale of Oncogeni Ltd
English 13.5 KB
2025-03-04 08:00
Regulatory News Service
Update on Sale of Lyramid
English 15.0 KB
2025-02-04 11:58
Director's Dealing
Director/PDMR Shareholding
English 35.8 KB
2025-02-03 08:00
Regulatory News Service
Share Purchase Agreement Signed - Sale of Lyramid
English 21.5 KB
2025-01-02 08:00
M&A Activity
Proposed Sale of Midkine Portfolio
English 16.2 KB

Automate Your Workflow. Get a real-time feed of all ROQUEFORT THERAPEUTICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ROQUEFORT THERAPEUTICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Theranexus Logo
Biopharma developing drug candidates for rare neurological diseases like Batten disease.
France ALTHX
TME Pharma N.V. Logo
Clinical-stage biotech developing TME-targeting therapies for aggressive cancers.
Germany ALTME
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
Transgene Logo
Clinical-stage biotech using viral vectors for cancer vaccines and oncolytic viruses.
France TNG
Tvardi Therapeutics Inc. Logo United States of America TVRD
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
Hong Kong N/A
Urteste S.A. Logo
Developing non-invasive urine tests for early detection & monitoring of multiple cancers.
Poland URT
VALIRX PLC Logo
Developing early-stage therapeutics & diagnostics for oncology and women's health.
United Kingdom VAL